Articles Posted in Mass Torts

You may be here because you or someone in your family has been diagnosed with acute myeloid leukemia (AML) or another blood cancer after years of benzene exposure. Benzene lawsuits most often focus on AML and related blood cancers linked to workplace or product exposure. These conditions are devastating on their own. When they are tied to a toxic chemical like benzene, the frustration is even greater.

Benzene has been tied to cancer for decades. The research is clear. Workers have brought benzene exposure lawsuits across the country, and juries have awarded significant verdicts in many cases. Families have negotiated benzene lawsuit settlements after showing that their exposure on the job or in the community caused leukemia, multiple myeloma, or other blood-related diseases.

If you are considering a benzene lawsuit, you are likely wondering how the process works, whether your case qualifies, and what kind of compensation is possible. The answers are specific to your situation, but the starting point is always the same: understanding how exposure happens and how the law allows victims to bring claims.

Women are still filing vaginal mesh lawsuits and bladder sling lawsuits in 2026, but this is no longer the enormous federal mass tort it was a decade ago. The old federal MDLs have closed. Most legacy claims have been resolved, and the remaining litigation is concentrated in individual cases and state-court dockets, including active Johnson & Johnson and Ethicon pelvic mesh cases in New Jersey.

A viable case now depends less on the history of the prior litigation and more on specific evidence: the manufacturer and product, the date of implantation, mesh erosion or another documented complication, revision surgery, and medical evidence linking the implant to the injury. Our lawyers are currently focused on selected claims involving products from Johnson & Johnson/Ethicon and Coloplast. We are not accepting new Boston Scientific mesh claims.

Substantively updated: October 1, 2026

C.R. Bard is defending over 18,000 hernia mesh lawsuits, which allege that its mesh devices were defective, resulting in injuries and complications for thousands of patients undergoing hernia surgery. Most of these lawsuits have now been joined in the Bard hernia mesh settlement, although new claims continue to come to our office virtually every day.

Our hernia mesh lawyers are handling these claims in all 50 states.  We are still taking new claims. This page will provide the latest news and updates on the hernia mesh litigation, as well as information regarding the settlement value of these cases.

Call our lawyers at 800-553-8082 for a free consultation or reach out online.

This page is about Truvada lawsuits and other HIV drug injury lawsuits involving kidney or bone injuries.

HIV drugs containing tenofovir disoproxil fumarate (TDF) are, we believe, putting patients at risk. This has resulted in HIV drug lawsuits from victims alleging kidney disease and failure, bone density loss, bone injuries, and other side effects.

Viread® and Truvada® are two of the first brand-name drugs developed by Gilead Sciences to treat HIV. Viread and Truvada both use tenofovir disoproxil fumarate (TDF), a new type of antiviral drug that was one of the first effective treatments for slowing HIV.

Our lawyers are handling Taxotere eye injury lawsuits throughout the United States for women with permanently watery eyes from docetaxel.

Taxotere (docetaxel) is a widely used breast cancer chemotherapy drug. New evidence has emerged showing that Taxotere may be causing some users to suffer permanent vision loss or damage.

This has led to a wave of product liability Taxotere lawsuits by women who claim that Taxotere damaged their eyesight. The manufacturer of Taxotere, Sanofi, allegedly knew about the risk of vision damage but chose not to warn doctors or patients about this risk.

Glucose monitor lawsuits are being filed by people who say continuous glucose monitoring systems failed when they needed them most. These lawsuits involve Dexcom G6, Dexcom G7, Abbott FreeStyle Libre 3, and Abbott FreeStyle Libre 3 Plus sensors, apps, and receivers that allegedly provided inaccurate glucose readings, missed high- or low-glucose alerts, failed early, or failed to warn users that glucose data had stopped reporting.

This is no small complaint for someone with diabetes who relies on these monitors. A continuous glucose monitor can drive decisions about insulin, food, sleep, exercise, and emergency care. When a sensor falsely reports low glucose, a patient may eat carbohydrates or delay insulin. When a device misses a low alert, a patient may seize, lose consciousness, fall, or die. When a high glucose event is missed, the result can be prolonged hyperglycemia, diabetic ketoacidosis, hospitalization, or worse.  Of course, a malfunctioning glucose monitor typically causes more minor injuries and inconveniences.

Our lawyers are looking for serious glucose monitor cases involving serious injury or death.

For sickle cell patients and families, Oxbryta was supposed to be a lifeline. Instead, it left many worse off–facing new health crises, hospitalizations, and in some cases, unthinkable loss. Now, Oxbryta lawsuits are uncovering what Pfizer knew and when it knew it.

Oxbryta is a prescription drug developed by Global Blood Therapeutics and later acquired by Pfizer. It was voluntarily recalled in September 2024 after new evidence revealed that it caused serious and potentially fatal complications, including vaso-occlusive crises and organ damage.

This page looks at Oxbryta lawsuits and their potential settlement value.

Oxbryta is a prescription drug made by Pfizer that was recalled in September 2024 after evidence revealed that it caused a number of very serious and potentially fatal health problems, including vaso-occlusive crisis and organ damage. Continue reading

Artificial intelligence has changed how people create, edit, and distribute images. But it has also opened a dangerous new frontier for exploitation and abuse. One of the most alarming developments is the rise of AI-generated sexual deepfakes: fake images or videos that can make it appear as though a real person was nude, sexualized, or involved in conduct that never happened.

The Grok deepfake lawsuit is one of the clearest early tests of whether AI companies can be held legally responsible when their tools generate or enable nonconsensual sexual images. These claims are not just about bad users. They are about product design, warnings, safeguards, profit, notice, and whether a company can release a powerful image-generation tool into the world and then blame victims when the predictable abuse occurs.

If your image, your child’s image, or someone you love was used in an AI-generated sexual deepfake, treat it like evidence in a serious civil case. Because it is. Screenshots help, but URLs, account names, timestamps, takedown requests, medical records, school records, employment records, and platform responses can all help. You do not need every piece of evidence to call, but the more we can preserve, the stronger the case may be.

Our lawyers are helping victims who want to bring a Gardasil HVP vaccine lawsuit throughout the United States.  Our law firm is particularly focused on ovarian failure cases that lead to infertility in women who have taken Gardasil in the last few years.

Gardasil is a vaccine intended to prevent human papillomavirus (HPV), which can sometimes lead to cervical cancer in women. Gardasil was developed by the embattled pharmaceutical company Merck & Co.

Merck obtained FDA approval for Gardasil in 2006 based on deceptive research and clinical trials that misrepresented the vaccine’s efficacy while concealing its safety risks and side effects. Merck then launched an aggressive and highly misleading marketing campaign to include millions of parents vaccinating their pre-teen daughters with Gardasil.

Contact Information